Clinical Trial Update: A Study of Neoadjuvant Therapy for the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Army Medical Center of PLA | Conditions: Neoadjuvant Therapy, Esophageal Squamous Cell Carcinoma | Phase 2, Phase 3 | Status: RECRUITING